Predictive Value and Optimal Cut-off Level of High-sensitivity Troponin T in Patients with Acute Pulmonary Embolism

Overview

Journal Korean J Intern Med

Date 2025 Jan 8

PMID 39778527

Authors

Moojun Kim

Chang-Ok Seo

Yong-Lee Kim

Hangyul Kim

Hye Ree Kim

Yun Ho Cho

Jeong Yoon Jang

Jong-Hwa Ahn

Min Gyu Kang

Kyehwan Kim

Jin-Sin Koh

Seok-Jae Hwang

Jin Yong Hwang

Jeong Rang Park

Affiliations

Soon will be listed here.

Abstract

Background/aims: Elevated troponin levels predict in-hospital mortality and influence decisions regarding thrombolytic therapy in patients with acute pulmonary embolism (PE). However, the usefulness of high-sensitivity troponin T (hsTnT) regarding PE remains uncertain. We aimed to establish the optimal cut-off level and compare its performance for precise risk stratification.

Methods: 374 patients diagnosed with acute PE were reviewed. PE-related adverse outcomes, a composite of PE-related deaths, cardiopulmonary resuscitation incidents, systolic blood pressure < 90 mmHg, and all-cause mortality within 30 days were evaluated. The optimal hsTnT cut-off for all-cause mortality, and the net reclassification index (NRI) was used to assess the incremental value in risk stratification.

Results: Among 343 normotensive patients, 17 (5.0%) experienced all-cause mortality, while 40 (10.7%) had PE-related adverse outcomes. An optimal hsTnT cut-off value of 60 ng/L for all-cause mortality (AUC 0.74, 95% CI 0.61-0.85, p < 0.001) was identified, which was significantly associated with PE-related adverse outcomes (OR 4.07, 95% CI 2.06-8.06, p < 0.001). Patients with hsTnT ≥ 60 ng/L were older, hypotensive, had higher creatinine levels, and right ventricular dysfunction signs. Combining hsTnT ≥ 60 ng/L with simplified pulmonary embolism severity index ≥1 provided additional prognostic information. Reclassification analysis showed a significant shift in risk categories, with an NRI of 1.016 ± 0.201 (p < 0.001).

Conclusion: We refined troponin's predictive value in patients with acute PE, proposing a new cut-off value of hsTnT ≥ 60 ng/L. Validation through large-scale studies is essential to offer clinically useful guidance for managing patient population.

References

Jimenez D, Aujesky D, Moores L, Gomez V, Lobo J, Uresandi F . Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010; 170(15):1383-9. DOI: 10.1001/archinternmed.2010.199. View

Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, Lobo J . Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008; 117(13):1711-6. DOI: 10.1161/CIRCULATIONAHA.107.726232. View

Gore M, Seliger S, deFilippi C, Nambi V, Christenson R, Hashim I . Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014; 63(14):1441-8. PMC: 3984900. DOI: 10.1016/j.jacc.2013.12.032. View

Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J . Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011; 32(11):1379-89. DOI: 10.1093/eurheartj/ehr033. View

Dietl A, Zimmermann M, Brandl C, Wallner S, Burkhardt R, Maier L . Distribution and specificity of high-sensitivity cardiac troponin T in older adults without acute cardiac conditions: cross-sectional results from the population-based AugUR study. BMJ Open. 2021; 11(11):e052004. PMC: 8565570. DOI: 10.1136/bmjopen-2021-052004. View

Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View

Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe A, Katus H . Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2009; 56(2):254-61. DOI: 10.1373/clinchem.2009.132654. View

Normann J, Mueller M, Biener M, Vafaie M, Katus H, Giannitsis E . Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J. 2012; 164(5):698-705.e4. DOI: 10.1016/j.ahj.2012.08.003. View

Hickman P, Abhayaratna W, Potter J, Koerbin G . Age-related differences in hs-cTnI concentration in healthy adults. Clin Biochem. 2019; 69:26-29. DOI: 10.1016/j.clinbiochem.2019.04.014. View

10.

Lega J, Lacasse Y, Lakhal L, Provencher S . Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis. Thorax. 2009; 64(10):869-75. DOI: 10.1136/thx.2008.110965. View

11.

Faller N, Limacher A, Mean M, Righini M, Aschwanden M, Beer J . Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. Am J Med. 2016; 130(2):198-206. DOI: 10.1016/j.amjmed.2016.09.008. View

12.

Giannitsis E, Katus H . Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol. 2013; 10(11):623-34. DOI: 10.1038/nrcardio.2013.129. View

13.

Ebner M, Sentler C, Harjola V, Bueno H, Lerchbaumer M, Hasenfuss G . Outcome of patients with different clinical presentations of high-risk pulmonary embolism. Eur Heart J Acute Cardiovasc Care. 2021; 10(7):787-796. PMC: 8483764. DOI: 10.1093/ehjacc/zuab038. View

14.

Pruszczyk P . N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. J Card Fail. 2005; 11(5 Suppl):S65-9. DOI: 10.1016/j.cardfail.2005.04.016. View

15.

Kozlowska M, Plywaczewska M, Koc M, Pacho S, Wyzgal A, Zdonczyk O . d-Dimer Assessment Improves the Simplified Pulmonary Embolism Severity Index for In-Hospital Risk Stratification in Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2018; 24(8):1340-1346. PMC: 6714762. DOI: 10.1177/1076029618776799. View

16.

Lankeit M, Friesen D, Aschoff J, Dellas C, Hasenfuss G, Katus H . Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J. 2010; 31(15):1836-44. DOI: 10.1093/eurheartj/ehq234. View

17.

Lankeit M, Jimenez D, Kostrubiec M, Dellas C, Hasenfuss G, Pruszczyk P . Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011; 124(24):2716-24. DOI: 10.1161/CIRCULATIONAHA.111.051177. View

18.

Welsh P, Preiss D, Shah A, McAllister D, Briggs A, Boachie C . Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort. Clin Chem. 2018; 64(11):1607-1616. PMC: 6398571. DOI: 10.1373/clinchem.2018.292086. View

19.

Konstantinides S, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V . 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2019; 41(4):543-603. DOI: 10.1093/eurheartj/ehz405. View

20.

Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M, Kurzyna M . N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J. 2003; 22(4):649-53. DOI: 10.1183/09031936.03.00023303. View